Solésence is cheap with a long runway for growthSolesence – NANX
Pitch Summary: Solesence has shown impressive growth since launching its proprietary zinc oxide formula, with sales reaching over $40M in 2024. Despite a significant rally, the stock is still undervalued at ~14x 2025e EPS. The company is poised for further growth with potential uplisting and continued expansion in the beauty market, offering a potential upside […]
